Instructions: In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
Input: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Robin Danielson Act''.

TITLE I--RESEARCH REGARDING RISKS POSED BY DIOXIN, SYNTHETIC FIBERS,
AND OTHER ADDITIVES IN FEMININE HYGIENE PRODUCTS

SEC. 101. FINDINGS.

The Congress finds as follows:
(1) Tampons are used by approximately 73,000,000 women in
the United States today, and the average woman may use as many
as 16,800 tampons in her lifetime. A woman on estrogen
replacement therapy may use as many as 24,360 tampons in her
lifetime.
(2) The Environmental Protection Agency and the
International Agency for Research on Cancer, an arm of the
World Health Organization, have concluded that dioxins are a
probable human carcinogen (cancer causing agent).
(3) Dioxin is a byproduct of chlorine-bleaching processes
used in the manufacture of paper products, including tampons,
sanitary pads, panty liners, and diapers.
(4) While bleaching processes that do not produce dioxin in
any amount are available, most pulp and paper manufacturers,
which produce the raw materials used in tampons, currently use
either elemental-chlorine or chlorine-dioxide bleaching
processes. Both of these bleaching processes use chlorine and
therefore produce dioxin.
(5) The effects of dioxin from various sources are
cumulative and can be measured 20 to 30 years after exposure.
Women may be exposed to dioxin in tampons and other menstrual
products for as long as 60 years over the course of their
reproductive lives.
(6) Internal documents of the Food and Drug Administration
suggest the agency has not adequately investigated the danger
of dioxin in tampons, according to a 1992 staff report of a
subcommittee of the Committee on Government Operations of the
House of Representatives.
(7) The Food and Drug Administration has historically
relied on data provided by manufacturers of feminine hygiene
products in determining product safety.
(8) Although the Food and Drug Administration currently
requires tampon manufacturers to monitor dioxin levels in their
finished products, the information is not readily available to
the public.
(9) Recent studies have produced conflicting information
about the link between dioxin exposure and increased risks for
endometriosis.
(10) The Environmental Protection Agency has concluded that
people with high levels of exposure to dioxins may be at risk
for other noncancer effects that could suppress the immune
system, increase the risk of pelvic inflammatory disease,
reduce fertility, and interfere with fetal and childhood
development.
(11) An independent study in 1991 found that tampons
commonly included one or more of the following additives:
Chlorine compounds, absorbency enhancers (such as surfactants
like polysorbate-20), natural and synthetic fibers (such as
cotton, rayon, polyester, and polyacrylate), deodorant, and
fragrance.
(12) Toxic Shock Syndrome (TSS) has been linked to tampon
use and the absorbency of the tampon. TSS is a rare bacterial
illness that occurs mostly in menstruating women. During 1979
and 1980, the syndrome was responsible for at least 55 deaths
and 1,066 nonfatal cases.
(13) In response to a 1988 lawsuit, the Food and Drug
Administration has required tampons to be labeled with
reference to an absorbency standard (e.g., super tampons must
absorb between 9 and 12 grams of liquid).
(14) Independent research has shown that synthetic fiber
additives in tampons amplify toxin production, which is
associated with toxic shock syndrome.

SEC. 102. NATIONAL INSTITUTES OF HEALTH; RESEARCH ON DIOXIN PURSUANT TO
OFFICE OF RESEARCH ON WOMEN'S HEALTH.

Part F of title IV of the Public Health Service Act (42 U.S.C. 287d
et seq.) is amended by adding at the end the following section:

''SEC. 486C. CERTAIN PROJECTS REGARDING WOMEN'S HEALTH.

''(a) Dioxin in Feminine Hygiene Products.--
''(1) In general.--The Director of NIH, in collaboration
with the Director of the Office, shall provide for the conduct
or support of research to determine the extent to which the
presence of dioxin, synthetic fibers, and other additives in
tampons and other feminine hygiene products--
''(A) poses any risks to the health of women who
use the products, including risks relating to cervical
cancer, endometriosis, infertility, ovarian cancer,
breast cancer, immune system deficiencies, pelvic
inflammatory disease, and toxic shock syndrome; and
''(B) poses any risks to the health of children of
women who used such products during or before the
pregnancies involved, including risks relating to fetal
and childhood development.
''(2) Requirement regarding data from manufacturers.--
Research under paragraph (1) shall include research to confirm
the data on tampons and other feminine hygiene products
submitted to the Commissioner of Food and Drugs by
manufacturers of such products.
''(3) Definition.--For purposes of paragraph (1), the term
'feminine hygiene products' means tampons, pads, liners, and
similar products used by women with respect to menstruation or
other genital-tract secretions.
''(b) Reports.--Reports on the results of research under subsection
(a) shall be periodically submitted to the Congress, the Commissioner
of Food and Drugs, the Administrator of the Environmental Protection
Agency, and the Chairman of the Consumer Product Safety Commission.
Such reports shall be made available to the public through the data
system and clearinghouse program established under section 486A, or
through other appropriate means.''.

TITLE II--COLLECTION AND ANALYSIS OF DATA ON TOXIC SHOCK SYNDROME

SEC. 201. FINDINGS.

The Congress finds as follows:
(1) Of the cases of toxic shock syndrome in the United
States, approximately 50 percent are related to tampon use and
approximately 50 percent occur in nonmenstruating women and in
men and children.
(2) The Centers for Disease Control and Prevention (CDC)
believes that women are at increased risk for developing toxic
shock syndrome due to a false sense of security that there is
no longer any risk for developing the disease.
(3) The CDC has estimated that each year such syndrome
strikes more than 1,300 individuals. Among women in the age
group 12 through 44 who use tampons or barrier contraceptives,
between one and two of every 100,000 will develop the syndrome.
(4) Epidemiological data on cases of toxic shock syndrome
are not systematically collected in the United States, and
information on cases seldom travels beyond the victim's circle
of family and friends.
(5) The CDC and the States should cooperate to collect and
analyze such data. Increasing the amount of information on
toxic shock syndrome will lead to increased awareness about the
disease in the medical community, and may also lead to an
increased understanding of the causes of the syndrome.

SEC. 202. CENTERS FOR DISEASE CONTROL AND PREVENTION; ESTABLISHMENT OF
PROGRAM FOR COLLECTION AND ANALYSIS OF DATA ON TOXIC
SHOCK SYNDROME.

Part B of title III of the Public Health Service Act (42 U.S.C. 243
et seq.) is amended by inserting after section 317S the following
section:

''SEC. 317T. COLLECTION AND ANALYSIS OF DATA ON TOXIC SHOCK SYNDROME.

''(a) In General.--The Secretary, acting through the Director of
the Centers for Disease Control and Prevention, shall carry out a
program to collect, analyze, and make available data on toxic shock
syndrome, including data on the causes of such syndrome.
''(b) National Incidence and Prevalence.--In carrying out the
program under subsection (a), the Secretary shall to the extent
practicable determine the national incidence and prevalence of toxic
shock syndrome.
''(c) Cooperation With States.--The Secretary may carry out the
program under subsection (a) directly and through grants to States and
local health departments.
''(d) Authorization of Appropriations.--For the purpose of carrying
out this section, there are authorized to be appropriated such sums as
may be necessary for each of the fiscal years 2006 through 2010.''.
Output:
Robin Danielson Act - Amends the Public Health Service Act to require the Director of the National Institutes of Health (NIH) to provide for the conduct or support of research on the extent to which additives in feminine hygiene products pose any risks to the health of women or the health of the children of women who use those products during or before the pregnancies involved.

Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collect, analyze, and make available data on toxic shock syndrome, including data on the causes of such syndrome; and (2) determine the national incidence and prevalence of such syndrome.